Formulation, optimization and characterization of nanostructured lipid carrier of nitrofurantoin
Abstract
Nitrofurantoin is effective against many urinary tract pathogens. It acts as bacteriostatic and/or bactericidal by inhibiting DNA-RNA protein& cell wall synthesis. Nanostructured Lipid Carriers (NLCs) of NFT was prepared by Hot Homogenization Process. Glyceryl Monostearate and Miglyol 812 were heated at 80ºC temperature on hot plate. In the melted lipid, drug was added with continuous stirring at high speed homogenization. Formulation NLC12B has % Entrapment efficiency 89.1 ± 0.5, PDI 0.11 ± 0.01 and mean particle size 237 ± 7nm represents narrow particle size distribution. Spherical feature of NLCs with better uniformity without aggregation of Nitrofurantoin loaded NLC was confirmed by TEM. Moreover, efficient miscibility of drug in lipids was confirmed by the absence of intense and characteristic peak of NFT in XRPD. After 6 month storage at 2-8°C there was no significant changes in the PDI as well as mean particle size.
Keywords:
Nitrofurantoin (NFT), Nanostructured Lipid Carriers (NLCs), Polydispersity Index (PDI) % Entrapment Efficiency (DOI
https://doi.org/10.25004/IJPSDR.2020.120304References
Praveen S, Gowda D, Srivastava A. Formulation and Evaluation of Nanostructured Lipid Carrier (NLC) For Glimepiride. Der Pharmacia lettre. 2016;8(7):251-256.
Fang Y-P, Lin Y-K, Su Y-H, Fang J-Y. Tryptanthrin-loaded nanoparticles for delivery into cultured human breast cancer cells, MCF7: The effects of solid lipid/liquid lipid ratios in the inner core. Chemical & Pharmaceutical Bulletin. 2011;59(2):266-271.
Sethuraman N, Shanmuganathan S, Anbarasan B. Design, Development and Characterization of Nano Structured Lipid Carrier for Topical Delivery of Aceclofena. Indian Journal of Pharmaceutical Education and Research. 2018;52(4):581-586.
Souza G, Silva J, Martins L. Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release. Eur. J Pharm Biopharm 2011;79:189-196
Gleckman R, Alvarez S. Drug therapy reviews nitrofurantoin. Am. J Hosp Pharm. 1979;36(3):342-51.
Ayush G, Anshu S, Indrajeet S. Preparation and evaluation of sustained release film coated tablets of nitrofurantoin. Int. J. of Res. in Pharmacy and Pharmaceutical Sci. 2016;1(1):47-53.
Nerella A, Basava R, Aruna D. Formulation, Optimization and In vitro Characterization of Letrozole Loaded Solid Lipid Nanoparticles. International Journal of Pharmaceutical Sciences and Drug Research. 2014;6(3):183-188.
Naglakshmi S, Shanmuganathan S, Sandhya K, Anbarasan B. Design, Development and Characterization of Nano Structured Lipid Carrier for of Aceclofenac. Ind. J. of Pharmaceutical Edu. and Res. 2018;52(4):581-586.
Parveen S, Sahoo K. Polymeric nanoparticles for cancer therapy. J Drug Target. 2008;16: 108-123.
Pawar RK, Lokhande R, Yadav R, Velankar S. A new HPLC assay method for determination and quantitation of nitrofurantoin. International journal of chemical and pharmaceutical analysis. 2016;4(1):1-7.
Gaur PK, Mishra S, Bajpai M, Mishra A. Enhanced Oral Bioavailability of Efavirenz by Solid Lipid Nanoparticles: In Vitro Drug Release and Pharmacokinetics Studies. BioMed Research International Volume. 2014; ID 363404: 9.
Poonia N, Kharb R, Lather V, Pandita D. Nanostructured lipid carriers: Versatile oral delivery vehicle. Future science OA. 2016;2(3):1-24.
Khosaa A, Reddia S, Saha R. Nanostructured lipid carriers for site-specific drug delivery. Biomedicine & Pharmacotherapy. 2018;108:598-613.
Patil D, Pattewar S, Sarvesh P, Gargi P, Sharma S. Nanostructured lipid carriers: A platform to lipophilic drug for oral bioavailability enhancement. Journal of Drug Delivery & Therapeutics. 2019;9(3-s):758-764.
Yiyin Chen, Xiaomin Yang, Lin Zhao, Vasil M, Aihua Zou. Preparation and characterization of a nanostructured lipid carrier fora poorly soluble drug. Colloids and Surfaces A: Physicochem. Eng. Aspects. 2014;455:36–43.
Dandagi PM, Gadad AP, Tigadi SG, Bolmal UB. Rosuvastatin Loaded Nanostructured Lipid Carrier: For Enhancement of Oral Bioavailability. Indian Journal of Pharmaceutical Education and Research. 2016;50(4):605-611.
Emami J, Rezazadeh M, Varshosaz J. Formulation of LDL Targeted Nanostructured Lipid Carriers loaded with Paclitaxel: A Detailed Study of Preparation, Freeze Drying Condition, and In Vitro Cytotoxicity. Journal of Nanomaterials. 2012; 358782:1-10.
The United States Pharmacopeia. Nitrofurantoin capsule. 2013.
Swidan SA, Mansour ZN, Mourad ZA, Elhesaisy ZA. DOE, formulation, and optimization of Repaglinide nanostructured lipid carriers. Journal of Applied Pharmaceutical Science. 2018;8(10):8-16.
Gadad AP, Tigadi SG, Dandagi PM, Bolmal UB. Rosuvastatin Loaded Nanostructured Lipid Carrier: For Enhancement of Oral Bioavailability. Indian Journal of Pharmaceutical Education and Research.2016;50(4):605-611.
Uprit S, Sahu RK, Roy A. Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia. Saudi Pharmaceutical Journal. 2013;21:379–385.
Almousallam M, Moia C, Zhu H. Development of nanostructured lipid carrier for dacarbazine delivery. Int Nano Lett. 2015;5:241–248.
Patel RP, Gaiakwad DR, Patel NA. Formulation, optimization, and evaluation of a transdermal patch of heparin sodium. Drug Discoveries & Therapeutics. 2014;8(4):185-193.
Patel D, Prajapati B. Extended Release Micro-pellets of Chiral Molecule of Metoprolol Succinate by Fluid Bed Technology. International Journal of Pharmaceutical Sciences and Drug Research 2017;9(1):10-16.
Published
Abstract Display: 551 
PDF Downloads: 537 
